VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Icariin
Preclinical
Small molecule
U
University of Texas Southwestern Medical Center
1
Indications
3
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Scar
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Scar
Preclinical
Completed
Clinical
Trials by Indication
[1]
Scar
1 trial
Topical Icariin on Acne and Acne Scars
Completed
·
S
Seoul National University Hospital
·
N/A
·
NCT07076784
·
25 enrolled
Bipolar Disorder
1 trial
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
Completed
·
U
University of Texas Southwestern Medical Center
·
Phase 3
·
NCT01979133
·
10 enrolled
Memory
1 trial
Icariin to Prevent Corticosteroid-related Memory Changes
Completed
·
U
University of Texas Southwestern Medical Center
·
Phase 1
·
NCT02112123
·
24 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
3 trial records for Icariin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Icariin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Icariin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Texas Southwestern Medical Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
University of Texas Southwestern Medical Center
Related News